BONE METASTASES

This large, late-stage trial is testing if a drug that helps prevent painful bone complications in people with metastatic breast or prostate cancer is just as effective when given every 12 weeks instead of the standard every 4 weeks. The goal is to see if the less frequent schedu…

This study is testing whether adding a highly focused, high-dose radiation treatment to standard care helps people with breast, lung, or prostate cancer that has spread to only a few bones (1-5 sites). It aims to see if this combined approach can keep the cancer from getting wors…

This study aims to find the best way to prevent dangerous blood clots in patients having surgery for bone or soft tissue cancer in the leg or pelvis. It will compare two common prevention methods: daily aspirin pills versus daily blood-thinner injections (LMWH). Researchers want …

This study is testing whether adding a supervised, 8-week exercise program to standard radiation treatment is safe, practical, and helpful for people with painful bone metastases from cancer. It aims to see if this combination can improve pain, physical function, and quality of l…

This study is testing whether a non-surgical treatment using focused sound waves (MR-HIFU), either alone or combined with standard radiation therapy, can relieve pain from cancer that has spread to the bones faster and better than radiation alone. It involves about 216 adult pati…

This study aims to create a better tool for predicting how long patients with cancer that has spread to their bones might live. Researchers are combining doctors' assessments with patients' own reports about their health to improve survival estimates. The goal is to help patients…

This study is testing whether special PET scans can predict how well hormone therapy will work for breast cancer that has spread to the bones. Researchers will scan 75 patients before treatment and again at 4 and 12 weeks after starting new therapy. They will compare the scan res…

This small study is testing a new type of PET scan to see if it can predict which patients with advanced HER2-positive breast cancer will benefit from a specific drug treatment. Researchers attach a tiny radioactive tag to a cancer drug and use a scanner to see where it goes in t…